Bristol Oncology Centre

Bristol BS2 8 ED

0 studies enrolling now · 2 studies all time

What they study most

Colorectal Neoplasms, Hormone Refractory Prostate Cancer, Prostate Cancer

Studies at this site

• Study of Tepotinib Combined With Cetuximab in Participants With Left-Sided RAS/BRAF Wild Type Metastatic Colorectal Cancer (PERSPECTIVE) — Stopped early
• Satraplatin in Hormone Refractory Prostate Cancer Patients Previously Treated With One Cytotoxic Chemotherapy Regimen — Completed